| Company/Division name | Amgen |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2020 |
| Domestically, the work will be done: | Both |
| City reshored to: | Thousand Oaks |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals, biopharmaceutical |
| Product(s) reshored | neutralizing antibodies, LY-CoV-555 |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Skilled workforce availability/training, Covid-19 |
